Pathogenesis and therapy for idiopathic dyspepsia

Current Gastroenterology Reports

Volumn 7, Issue 6, 2005, Pages 437-444

  Tack, Jan ^a   Kindt, Sébastien ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CHAMOMILE; CISAPRIDE; ERYTHROMYCIN; FAMOTIDINE; GUANINE NUCLEOTIDE BINDING PROTEIN; HERBACEOUS AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; ITOPRIDE; LANSOPRAZOLE; MACROLIDE; MOSAPRIDE CITRATE; OMEPRAZOLE; PEPPERMINT; PLACEBO; PROKINETIC AGENT; PROTON PUMP INHIBITOR; RANITIDINE; SODIUM CHLORIDE; STOMACH SECRETION INHIBITOR; SULPIRIDE; TANDOSPIRONE; UNCLASSIFIED DRUG;

ABDOMINAL DISCOMFORT; CLINICAL TRIAL; DYSPEPSIA; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL INFECTION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HEART ARRHYTHMIA; HUMAN; IBERIS AMARA; IRRITABLE COLON; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; SIDE EFFECT; SOCIAL PSYCHOLOGY; STOMACH MOTILITY;

DYSPEPSIA; GASTROENTERITIS; GASTROINTESTINAL AGENTS; GASTROINTESTINAL MOTILITY; HUMANS; STRESS, PSYCHOLOGICAL; TREATMENT OUTCOME;

EID: 29444457093     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-005-0073-2     Document Type: Review

References (74)

1. Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ III: Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 1992, 102:1259-1268.
2. El-Serag HB, Talley NJ: Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther 2004, 19:643-654.
3. Klauser AG, Voderholzer WA, Knesewitsch PA, et al.: What is behind dyspepsia? Dig Dis Sci 1993, 38:147-154.
4. Talley NJ, Stanghellini V, Heading RC, et al.: Functional gastroduodenal disorders. Gut 1999, 45(suppl II):37-42.
5. Locke GR III, Zinsmeister AR, Fett SL, et al.: Overlap of gastrointestinal symptom complexes in a US community. Neurogastroenterol Motil 2005, 17:29-34.
6. Hammer J, Eslick GD, Howell SC, et al.: Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia. Gut 2004, 53:666-672.
7. Shaib Y, El-Serag HB: The prevalence and risk factors of functional dyspepsia in a multiethnic population in the United States. Am J Gastroenterol 2004, 99:2210-2216.
8. Gerson LB, Triadafilopoulos G: A prospective study of oesophageal 24-h ambulatory PH monitoring in patients with functional dyspepsia. Dig Liver Dis 2005, 37:87-91.
9. Tack J, Caenepeel P, Arts J, et al.: Prevalence and symptomatic impact of non-erosive reflux disease in functional dyspepsia. Gut 2005, 54:1370-1376.
10. Holtmann G, Siffert W, Haag S, et al.: G-protein beta 3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia. Gastroenterology 2004, 126:971-979.
11. Tack J, Demedts I, Dehondt G, et al.: Clinical and pathophysiological characteristics of acute-onset functional dyspepsia. Gastroenterology 2002, 122:1738-1747.
12. Mearin F, Perez-Oliveras M, Perello A, et al.: Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. Gastroenterology 2005, 129:98-104.
13. Hall W, Buckley M, Crotty P, O'Morain CA: Gastric mucosal mast cells are increased in Helicobacter pylori-negative functional dyspepsia. Clin Gastroenterol Hepatol 2003, 1:363-369.
14. Moayyedi P, Soo S, Deeks J, et al.: Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2005, Jan 25, (1):CD002096.
15. Tack J, Bisschops R, Sarnelli G: Pathophysiology and treatment of functional dyspepsia. Gastroenterology 2004, 127:1239-1255.
16. Sarnelli G, Cuomo R, Janssens J, Tack J: Symptom patterns and pathophysiological mechanisms in dyspeptic patients with and without Helicobacter pylori. Dig Dis Sci 2003, 48:2229-2236.
17. Hsu PI, Lai KH, Tseng HH, et al.: Eradication of Helicobacter pylori prevents ulcer development in patients with ulcer-like functional dyspepsia. Aliment Pharmacol Ther 2001, 15:195-201.
18. Heikkinen M, Vornanen M, Hollmen S, Farkkila M: Prognostic significance of antrum-predominant gastritis in functional dyspepsia. Scand J Gastroenterol 2004, 39:227-231.
19. Haag S, Talley NJ, Holtmann G: Symptom patterns in functional dyspepsia and irritable bowel syndrome: relationship to disturbances in gastric emptying and response to a nutrient challenge in consulters and non-consulters. Gut 2004, 53:1445-1451.
20. Hou XH, Li Q, Zhu L, et al.: Correlation of gastric liquid emptying with various thresholds of sensation in healthy controls and patients with functional dyspepsia. Dig Dis Sci 2004, 49:188-195.
21. Loreno M, Bucceri AM, Catalano F, et al.: Pattern of gastric emptying in functional dyspepsia. An ultrasonographic study. Dig Dis Sci 2004, 49:404-407.
22. Lorena SL, Tinois E, Brunetto SQ, et al.: Gastric emptying and intragastric distribution of a solid meal in functional dyspepsia: influence of gender and anxiety. J Clin Gastroenterol 2004, 38:230-236.
23. Bredenoord AJ, Chial HJ, Camilleri M, et al.: Gastric accommodation and emptying in evaluation of patients with upper gastrointestinal symptoms. Clin Gastroenterol Hepatol 2003, 1:264-272.
24. Boeckxstaens GE, Hirsch DP, van den Elzen BD, et al.: Impaired drinking capacity in patients with functional dyspepsia: relationship with proximal stomach function. Gastroenterology 2001, 121:1054-1063.
25. Chen CL, Lin HH, Chen MC, Huang LC: Dyspeptic symptoms and water load test in patients with functional dyspepsia and reflux disease. Scand J Gastroenterol 2005, 40:28-32.
26. Jones MP, Roth LM, Crowell MD: Symptom reporting by functional dyspeptics during the water load test. Am J Gastroenterol 2005, 100:1334-1339.
27. Hjelland IE, Ofstad AP, Narvestad JK, et al.: Drink tests in functional dyspepsia: which drink is best? Scand J Gastroenterol 2004, 39:933-937.
28. Montano-Loza A, Schmulson M, Zepeda-Gomez S, et al.: Maximumz tolerated volume in drinking tests with water and a nutritional beverage for the diagnosis of functional dyspepsia. World J Gastroenterol 2005, 11:3122-3126.
29. Tack J, Piessevaux H, Coulie B, et al.: Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998, 115:1346-1352.
30. Tack J, Caenepeel P, Piessevaux H, et al.: Assessment of meal induced gastric accommodation by a satiety drinking test in health and in severe functional dyspepsia. Gut 2003, 52:1271-1277.
31. Gonenne J, Castillo EJ, Camilleri M, et al.: Does the nutrient drink test accurately predict postprandial gastric volume in health and community dyspepsia? Neurogastroenterol Motil 2005, 17:44-50.
32. Delgado-Aros S, Camilleri M, et al.: Contributions of gastric volumes and gastric emptying to meal size and postmeal symptoms in functional dyspepsia. Gastroenterology 2004, 127:1685-1694.
33. Tack J, Bisschops R: Mechanisms underlying meal-induced symptoms in functional dyspepsia. Gastroenterology 2004, 127:1844-1847.
34. Sarnelli G, Vandenberghe J, Tack J: Visceral hypersensitivity in functional disorders of the upper gastrointestinal tract. Dig Liver Dis 2004, 36:371-376.
35. Corsetti M, Caenepeel P, Fischler B, et al.: Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia. Am J Gastroenterol 2004, 99:1152-1159.
36. Bouin M, Lupien F, Riberdy M, et al.: Intolerance to visceral distension in functional dyspepsia or irritable bowel syndrome: an organ specific defect or a pan intestinal dysregulation? Neurogastroenterol Motil 2004, 16:311-314.
37. Piessevaux H, Tack J, Wilmer A, et al.: Perception of changes in wall tension of the proximal stomach in humans. Gut 2001, 49:203-208.
38. Tack J, Caenepeel P, Corsetti M, Janssens J: Role of tension receptors in dyspeptic patients with hypersensitivity to gastric distention. Gastroenterology 2004, 127:1058-1066.
39. Monnikes H, van der Voort IR, Wollenberg B, et al.: Gastric perception thresholds are low and sensory neuropeptide levels high in helicobacter pylori-positive functional dyspepsia. Digestion 2005, 71:111-123.
40. Vandenberghe J, Vos R, Persoons P, et al.: Dyspeptic patients with visceral hypersensitivity: sensitisation of pain specific or multimodal pathways? Gut 2005, 54:914-919.
41. Lu CL, Wu YT, Yeh TC, et al.: Neuronal correlates of gastric pain induced by fundus distension: a 3T-fMRI study. Neurogastroenterol Motil 2004, 16:575-587.
42. Vandenberghe J, Dupont P, Fischler B, et al.: Regional brain activation during proximal stomach distention in humans: a positron emission tomography study. Gastroenterology 2005, 128:564-573.
43. van Oudenhove L, DuPont P, Vandenberghe J, et al.: Reply. Gastroenterology, 128:1530-1531.
44. Feinle-Bisset C, Vozzo R, Horowitz M, Talley NJ: Diet, food intake, and disturbed physiology in the pathogenesis of symptoms in functional dyspepsia. Am J Gastroenterol 2004, 99:170-181.
45. Oba-Kuniyoshi AS, Oliveira JA Jr, Moraes ER, Troncon LE: Postprandial symptoms in dysmotility-like functional dyspepsia are not related to disturbances of gastric myoelectrical activity. Braz J Med Biol Res 2004, 37:47-53.
46. Lee KJ, Demarchi B, Demedts I, et al.: A pilot study on duodenal acid exposure and its relationship to symptoms in functional dyspepsia with prominent nausea. Am J Gastroenterol 2004, 99:1765-1773.
47. He MR, Song YG, Zhi FC: Gastrointestinal hormone abnormalities and G and D cells in functional dyspepsia patients with gastric dysmotility. World J Gastroenterol 2005, 11:443-446.
48. Lankarani KB, Moghadami M, Masoumpoor M, et al.: Serum leptin level in patients with functional dyspepsia. Dig Liver Dis 2004, 36:717-721.
49. Van Oudenhove L, Demyttenaere K, Tack J, Aziz Q: Central nervous system involvement in functional gastrointestinal disorders. Best Pract Res Clin Gastroenterol 2004, 18:663-680.
50. Locke GR III, Weaver AL, Melton LJ, III, Talley NJ: Psychosocial factors are linked to functional gastrointestinal disorders: a population based nested case-control study. Am J Gastroenterol 2004, 99:350-357.
51. Haider SL, Locke GR III, Talley NJ, et al.: Impact of functional gastrointestinal disorders on health-related quality of life: a population-based case-control study. Aliment Pharmacol Ther 2004, 19:233-242.
52. Koloski NA, Boyce PM, Talley NJ: Is health care seeking for irritable bowel syndrome and functional dyspepsia a socially learned response to illness? Dig Dis Sci 2005, 50:153-162.
53. Jones MP, Schettler A, Olden K, Crowell MD: Alexithymia and somatosensory amplification in functional dyspepsia. Psychosomatics 2004, 45:508-516.
54. Jones MP, Maganti K: Symptoms, gastric function, and psychosocial factors in functional dyspepsia. J Clin Gastroenterol 2004, 38:866-872.
55. Pajala M, Heikkinen M, Hintikka J: Mental distress in patients with functional or organic dyspepsia: a comparative study with a sample of the general population. Aliment Pharmacol Ther 2005, 21:277-281.
56. Biggs AM, Aziz Q, Tomenson B, Creed F: Effect of childhood adversity on health related quality of life in patients with upper abdominal or chest pain. Gut 2004, 53:180-186.
57. Cheng C, Hui WM, Lam SK: Psychosocial factors and perceived severity of functional dyspeptic symptoms: a psychosocial interactionist model. Psychosom Med 2004, 66:85-91.
58. Vege SS, Locke GR III, Weaver AL, et al.: Functional gastrointestinal disorders among people with sleep disturbances: a population-based. study. Mayo Clin Proc 2004, 79:1501-1506.
59. Delgado-Aros S, Cremonini F, Talley NJ: Treatment of functional dyspepsia. Curr Treat Opt Gastroenterol 2004, 7:121-131.
60. Abraham NS, Moayyedi P, Daniels B, et al.: Systematic review: the methodological quality of trials affects estimates of treatment efficacy in functional (non-ulcer) dyspepsia. Aliment Pharmacol Ther 2004, 19:631-641.
61. Madsen LG, Wallin L, Bytzer P: Identifying response to acid suppressive therapy in functional dyspepsia using a random starting day trial: Is gastro-oesophageal reflux important? Aliment Pharmacol Ther 2004, 20:423-430.
62. Madsen LG, Bytzer P: Reproducibility of a symptom response to omeprazole therapy in functional dyspepsia evaluated by a random-starting-day trial design. Aliment Pharmacol Ther 2004, 20:365-372.
63. Kato M, Watanabe M, Konishi S, et al.: Randomized, double-blind, placebo-controlled crossover trial of famotidine in patients with functional dyspepsia. Aliment Pharmacol Ther 2005, 21(Suppl 2):27-31.
64. Kinoshita Y, Hashimoto T, Kawamura A, et al.: Effects of famotidine, mosapride and tandospirone for treatment of functional dyspepsia. Aliment Pharmacol Ther 2005, 21(Suppl 2):37-41.
65. Seno H, Nakase H, Chiba T. Usefulness of famotidine in functional dyspepsia patient treatment: comparison among prokinetic, add suppression and antianxiety therapies. Aliment Pharmacol Ther 2005, 21(Suppl 2):32-36.
66. Holtmann G, Kutscher SU, Haag S, et al.: Clinical presentation and personality factors are predictors of the response to treatment in patients with functional dyspepsia, a randomized, double-blind placebo-controlled crossover study. Dig Dis Sci 2004, 49:672-679.
67. Peura DA, Kovacs TO, Metz DC, et al.: Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials. Am J Med 2004, 116:740-748.
68. Gisbert JP, Cruzado AI, Garcia-Gravalos R, Pajares JM: Lack of benefit of treating Helicobacter pylori infection in patients with functional dyspepsia: randomized one-year follow-up study. Hepatogastroenterology 2004, 51:303-308.
69. Mearin F, Rodrigo L, Perez-Mota A, et al.: Levosulpiride and cisapride in the treatment of dysmotility-like functional dyspepsia: a randomized, double-masked trial. Clin Gastroenterol Hepatol 2004, 2:301-308.
70. Tack J, Peeters T: What comes after macrolides and other motilin stimulants? Gut 2001, 49:317-318.
71. Arts J, Caenepeel P, Verbeke K, Tack J: Influence of erythromycin on gastric emptying and meal related symptoms in functional dyspepsia with delayed gastric emptying. Gut 2005, 54:455-460.
72. Amarapurkar DN, Rane P: Randomised, double-blind, comparative study to evaluate the efficacy and safety of ganaton (itopride hydrochloride) and mosapride citrate in the management of functional dyspepsia. J Indian Med Assoc 2004, 102:735-737, 760.
73. Madisch A, Holtmann G, Mayr G, et al.: Treatment of functional dyspepsia with a herbal preparation: a double-blind, randomized, placebo-controlled, multicenter trial. Digestion 2004, 69:45-52.
74. Melzer J, Rosch W, Reichling J, et al.: Meta-analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5 (Iberogast). Aliment Pharmacol Ther 2004, 20:1279-1287.